Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Recurrent Adult Acute Lymphoblastic Leukemia Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, visits or treatment by using a genuine doctor. We aren't physicians. Always confer with your physician about Recurrent Adult Acute Lymphoblastic Leukemia conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Recurrent Adult Acute Lymphoblastic Leukemia Clinical research trials and Recurrent Adult Acute Lymphoblastic Leukemia medical trials occur in hundreds of localities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually assess the effectiveness of new does drugs. The purpose of the studies / projects is to answer particular human medical questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all sorts of conditions, such as Recurrent Adult Acute Lymphoblastic Leukemia. Recurrent Adult Acute Lymphoblastic Leukemia Clinical Trials and other clinical trials allow for volunteers to access healthcare treatment choices before they are available to the general public. Many times the participants receive treatment for free, and occasionally they are paid for their time. Occasionally there is a cost for a Recurrent Adult Acute Lymphoblastic Leukemia clinical trial. Subjects frequently receive the best healthcare available for their Recurrent Adult Acute Lymphoblastic Leukemia affliction. Risks are a reality, nevertheless, and might include extra or frequent physician visits, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with stern guidelines to protect clinical trials patients.

Home > Clinical Trials by Conditions > "R" Clinical Trial Conditions > Recurrent Adult Acute Lymphoblastic Leukemia Clinical Trials

Recurrent Adult Acute Lymphoblastic Leukemia Clinical Trials



3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center

506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
Condition: southwest_oncology_group_clinical_trials.html
Southwest Oncology Group

506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Condition: memorial_sloankettering_cancer_center_clinical_trials.html
Memorial Sloan-Kettering Cancer Center

Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
Condition: h_lee_moffitt_cancer_center_and_research_institute_clinical_trials.html
H. Lee Moffitt Cancer Center and Research Institute

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia
Condition: fred_hutchinson_cancer_research_center_clinical_trials.html
Fred Hutchinson Cancer Research Center

Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Condition: roswell_park_cancer_institute_clinical_trials.html
Roswell Park Cancer Institute

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia
Condition: medical_college_of_pennsylvania_hospital_clinical_trials.html
Medical College of Pennsylvania Hospital

Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia
Condition: medizinische_hochschule_hannover_clinical_trials.html
Medizinische Hochschule Hannover

Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia
Condition: sidney_kimmel_cancer_center_clinical_trials.html
Sidney Kimmel Cancer Center

Fludarabine and Total-Body Irradiation Followed By Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate
Condition: fred_hutchinson_cancer_research_center_clinical_trials.html
Fred Hutchinson Cancer Research Center

FR901228 in Treating Patients With Hematologic Cancer
Condition: arthur_g_james_cancer_hospital__richard_j_solove_research_institute_clinical_trials.html
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute

Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation
Condition: fred_hutchinson_cancer_research_center_clinical_trials.html
Fred Hutchinson Cancer Research Center

Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia
Condition: arthur_g_james_cancer_hospital__richard_j_solove_research_institute_clinical_trials.html
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute

Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Condition: parker_hughes_institute_clinical_trials.html
Parker Hughes Institute

Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center

Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center



Recurrent Adult Acute Lymphoblastic Leukemia Clinical Trials

Modify your Search

Recurrent Adult Acute Lymphoblastic Leukemia Clinical Trials by State:

Alabama
Arizona
Arkansas
California
Colorado
Delaware
District Of Columbia
Florida
Georgia
Hawaii
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
Wisconsin

Other "R" Clinical Trials Conditions:

Radiation Enteritis
Radiation Fibrosis
Radiation Injuries
Radiation Toxicity
Radiculitis
Radiculopathy
Raman Spectroscopy
Rapid Cycling Bipolar Disorder
Raynaud Disease
Raynaud's Disease
Rectal Cancer
Rectal Neoplasms
Recurrence
Recurrent Abdominal Pain
Recurrent Adenoid Cystic Carcinoma Of The Oral Cavity
Recurrent Adrenocortical Carcinoma
Recurrent Adult Acute Lymphoblastic Leukemia
Recurrent Adult Acute Lymphocytic Leukemia
Recurrent Adult Acute Myeloid Leukemia
Recurrent Adult Brain Tumor
Recurrent Adult Burkitt's Lymphoma
Recurrent Adult Diffuse Large Cell Lymphoma
Recurrent Adult Diffuse Mixed Cell Lymphoma
Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
Recurrent Adult Diffuse Small Noncleaved Cell/burkitt's Lymphoma
Recurrent Adult Hodgkin's Disease
Recurrent Adult Hodgkin's Lymphoma
Recurrent Adult Immunoblastic Large Cell Lymphoma
Recurrent Adult Lymphoblastic Lymphoma
Recurrent Adult Non-Hodgkin's Lymphoma
Recurrent Adult Primary Liver Cancer
Recurrent Adult Soft Tissue Sarcoma
Recurrent Adult T-Cell Leukemia/lymphoma
Recurrent Angiocentric Immunoproliferative Lesions
Recurrent Bladder Cancer
Recurrent Brain Tumor
Recurrent Breast Cancer
Recurrent Carcinoma Of Unknown Primary
Recurrent Cervical Cancer
Recurrent Childhood Acute Lymphoblastic Leukemia
Recurrent Childhood Acute Myeloid Leukemia
Recurrent Childhood Brain Stem Glioma
Recurrent Childhood Brain Tumor
Recurrent Childhood Cerebellar Astrocytoma
Recurrent Childhood Cerebral Astrocytoma
Recurrent Childhood Ependymoma
Recurrent Childhood Hodgkin's Disease
Recurrent Childhood Large Cell Lymphoma
Recurrent Childhood Liver Cancer
Recurrent Childhood Lymphoblastic Lymphoma
Recurrent Childhood Malignant Germ Cell Tumor
Recurrent Childhood Medulloblastoma
Recurrent Childhood Rhabdomyosarcoma
Recurrent Childhood Small Noncleaved Cell Lymphoma
Recurrent Childhood Soft Tissue Sarcoma
Recurrent Childhood Supratentorial Primitive Neuroectodermal And Pineal Tumors
Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumors
Recurrent Childhood Visual Pathway Glioma
Recurrent Colon Cancer
Recurrent Cutaneous T-Cell Lymphoma
Recurrent Diffuse Small Lymphocytic/marginal Zone Lymphoma
Recurrent Endometrial Cancer
Recurrent Esophageal Cancer
Recurrent Extrahepatic Bile Duct Cancer
Recurrent Gallbladder Cancer
Recurrent Gastric Cancer
Recurrent Gastrointestinal Carcinoid Tumor
Recurrent Gestational Trophoblastic Tumor
Recurrent Grade 1 Follicular Lymphoma
Recurrent Grade 2 Follicular Lymphoma
Recurrent Grade 3 Follicular Lymphoma
Recurrent Grade I Follicular Small Cleaved Cell Lymphoma
Recurrent Grade Ii Follicular Mixed Cell Lymphoma
Recurrent Grade Iii Follicular Large Cell Lymphoma
Recurrent Intraocular Melanoma
Recurrent Kaposi's Sarcoma
Recurrent Malignant Mesothelioma
Recurrent Malignant Thymoma
Recurrent Mantle Cell Lymphoma
Recurrent Melanoma
Recurrent Merkel Cell Carcinoma
Recurrent Metastatic Squamous Neck Cancer With Occult Primary
Recurrent Mycosis Fungoides/sezary Syndrome
Recurrent Neuroblastoma
Recurrent Non-Small Cell Lung Cancer
Recurrent Osteosarcoma
Recurrent Ovarian Epithelial Cancer
Recurrent Ovarian Germ Cell Tumor
Recurrent Pancreatic Cancer
Recurrent Peripheral Primitive Neuroectodermal Tumor
Recurrent Prostate Cancer
Recurrent Rectal Cancer
Recurrent Renal Cell Cancer
Recurrent Respiratory Papillomatosis
Recurrent Retinoblastoma
Recurrent Salivary Gland Cancer
Recurrent Skin Cancer
Recurrent Small Cell Lung Cancer
Recurrent Small Intestine Cancer
Recurrent Small Lymphocytic Lymphoma
Recurrent Squamous Cell Carcinoma Of The Hypopharynx
Recurrent Squamous Cell Carcinoma Of The Larynx
Recurrent Squamous Cell Carcinoma Of The Lip And Oral Cavity
Recurrent Squamous Cell Carcinoma Of The Nasopharynx
Recurrent Squamous Cell Carcinoma Of The Oropharynx
Recurrent Squamous Cell Carcinoma Of The Paranasal Sinus And Nasal Cavity
Recurrent Testicular Cancer
Recurrent Thymoma And Thymic Carcinoma
Recurrent Thyroid Cancer
Recurrent Transitional Cell Cancer Of The Renal Pelvis And Ureter
Recurrent Tumors Of The Ewing's Family
Recurrent Urethral Cancer
Recurrent Uterine Sarcoma
Recurrent Vulvar Cancer
Recurrent Wilms' Tumor And Other Childhood Kidney Tumors
Recurrent/refractory Childhood Hodgkin's Disease
Recurrent/refractory Childhood Hodgkin's Lymphoma
Red-Cell Aplasia, Pure
Reduction Of Total Body Iron Storage(tbis)
Reflex Sympathetic Dystrophy
Refractive Error
Refractory Anemia
Refractory Anemia With Excess Blasts
Refractory Anemia With Excess Blasts In Transformation
Refractory Anemia With Ringed Sideroblasts
Refractory Chronic Lymphocytic Leukemia
Refractory Chronic Myelogenous Leukemia
Refractory Cytopenia
Refractory Hairy Cell Leukemia
Refractory Lymphoma
Refractory Plasma Cell Neoplasm
Regional Gastrointestinal Carcinoid Tumor
Regional Neuroblastoma
Regional Transitional Cell Cancer Of The Renal Pelvis And Ureter
Rehabilitation
Reiter's Disease
Relapsed Lymphoma
Relapsing Chronic Myelogenous Leukemia
Relapsing-Remitting Multiple Sclerosis
Renal Allograft Recipients
Renal Anemia
Renal Artery Obstruction
Renal Cancer
Renal Cell Adenocarcinoma
Renal Cell Cancer
Renal Cell Carcinoma
Renal Clear Cell Carcinoma
Renal Failure
Renal Granular Cell Carcinoma
Renal Insufficiency, Chronic
Renal Neoplasm
Renal Osteodystrophy
Renal Transplant Recipients
Renovascular Hypertension
Reproductive Cancer
Reproductive Cancers
Respiration Disorders
Respiratory Acidosis
Respiratory Distress Syndrome
Respiratory Distress Syndrome, Adult
Respiratory Insufficiency
Respiratory Papillomas
Respiratory Syncytial Virus Infection
Respiratory Syncytial Virus Infections
Respiratory Tract Diseases
Rest Leg Pain
Restless Legs Syndrome
Retinal Degeneration
Retinal Detachment
Retinal Disease
Retinal Diseases
Retinal Hemangioblastoma
Retinal Neovascularization
Retinal Vasculitis
Retinal Vein Occlusion
Retinitis
Retinitis Pigmentosa
Retinoblastoma
Retinopathy Of Prematurity
Retinoschisis
Retroviridae Infections
Rett Syndrome
Rhabdoid Tumor Of The Kidney
Rhabdomyosarcoma
Rheumatic Disease
Rheumatic Diseases
Rheumatoid Arthritis
Rhinitis
Rhinitis, Allergic, Nonseasonal
Rhinitis, Allergic, Seasonal
Rickets


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103